Thrombosis and Haemostasis · 2005 · 16 citations · 4 references
MedicineHematologyPharmacotherapyAutoimmunityHemostasisPediatric HematologyCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesHemolytic DisordersHemostatic DisordersThrombotic DisordersAcquired Coagulation DisordersBleedingFactor ViiaFactor Viii ActivationManagement Of Bleeding ComplicationsProthrombin ActivationRare Bleeding DisordersRecombinant Activated Factor Vii
Acquired hemophilia A is a rare disease caused by autoantibodies to factor (F) VIII. It usually affects elderly patients resulting in serious bleeding complications. Whereas acute bleeding is often successfully treated by activated prothrombin complexes or recombinant factor VIIa, long term eradication therapy of the inhibitor remains a matter of debate in the absence of prospective controlled trials. We here describe the case of a 14-year-old girl in whom a FVIII autoantibody has been successfully treated by a relatively mild immunosuppressive regimen including mycophenolate mofetil.
4
Pharmacokinetics of mycophenolate mofetil for autoimmune disease in children
Guido Filler, Miriam Hansen, Claire LeBlanc et al. · Pediatric Nephrology · 2003 · 71 citations